✦ LIBER ✦

Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma

✍ Scribed by Huijgens, P.C.; Ossenkoppele, G.J.; Van Der Lelie, J.; Thomas, L.L.M.; Wijngaarden, M.J.; Reijneke, R.M.R.

Book ID: 122939267
Publisher: Elsevier Science
Year: 1988
Weight: 422 KB
Volume: 24
Category: Article
ISSN: 0277-5379
DOI: 10.1016/S0277-5379(98)90021-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IMVP-16 followed by high dose chemothera

IMVP-16 followed by high dose chemotherapy and autologous bone marrow transplantation as salvage treatment for malignant lymphoma

✍ P. C. Huijgens; G. J. Ossenkoppele; J. Van Der Lelie; L. L. M. Thomas; M. J. Wij 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Thirty patients with high-grade malignant lymphoma were treated with ifosfamide-VP16213-methotrexate (IMVP-16) combination chemotherapy after failing to respond completely or after relapsing on CHOP-like therapy. Responders to the salvage therapy subsequently were treated with ablative chemotherapy

Combination chemotherapy with ifosfamide

Combination chemotherapy with ifosfamide and nimustine (IMA) as salvage treatment for small cell lung cancer

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 106 KB

A Combination Chemotherapy Protocol with

A Combination Chemotherapy Protocol with Dose Intensification and Autologous Bone Marrow Transplant (VELCAP-HDC) for Canine Lymphoma

✍ Angela E. Frimberger; Antony S. Moore; Kenneth M. Rassnick; Susan M. Cotter; Jen 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

High dose chemotherapy with ifosfamide,

High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults

✍ Jean-Pierre Droz; Pierre Biron; Jean-Pierre Lotz 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 2 views

High dose combination chemotherapy (TACC

High dose combination chemotherapy (TACC) with and without autologous bone marrow transplantation for the treatment of acute leukaemia and other malignant diseases: Kinetics of recovery of haemopoiesis. A preliminary study of 12 cases

✍ N.C. Gorin; A. Najman; Ch. Salmon; J.Y. Muller; J.C. Petit; R. David; J. Stachow 📂 Article 📅 1979 🏛 Elsevier Science ⚖ 498 KB

High dose therapy and autologous stem ce

High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin’s lymphoma: Abstracted from: Federico M, Bellei M, Brice P et al. High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin’s lymphoma responding to front-line therapy. Journal of Clinical Oncology 2003; 21: 2320–2325

📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 83 KB